Over 29,000 kg of butter recalled in US for skipping one key word: Milk
Bunge North America
Inc. and later classified by the US Food and Drug Administration (FDA) as a Class II recall on July 30.
The butter, distributed in 500-gram blocks under the NH European Style Butter Blend label, was packed in 1,800 cases. Each case contained 36 butter blocks and was shipped to 12 distribution centres across the US and one in the Dominican Republic. The company initiated the recall on July 14.
Milk not listed as ingredient
Though butter is made from cream, which is derived from milk, the ingredient was not clearly mentioned on the label. Milk is considered a major allergen and must be declared under FDA regulations.
The FDA defines a Class II recall as 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.'
No illnesses reported yet
So far, there are no reports of any allergic reactions linked to the recalled butter. However, the omission is considered serious due to the risk it poses to people with milk allergies. The FDA has advised that if someone with a milk allergy has consumed the butter and experiences symptoms, they should 'stop eating the food immediately, evaluate the need to use emergency medication (such as epinephrine) and seek medical attention.'
Live Events
Understanding food allergy risks
Food allergies can cause reactions ranging from mild discomfort, such as hives or swelling, to severe, life-threatening conditions like
anaphylaxis
. This occurs when the immune system reacts aggressively and can lead to shock if not treated promptly.
To prevent such risks, the FDA mandates that food packaging must clearly state the presence of any of the eight major allergens, including milk.
This recall follows another incident earlier in the week involving High Noon Hard Seltzers. A labelling error led to some vodka-containing cans being incorrectly packaged as non-alcoholic Celsius Astro Vibe Energy Drinks.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
4 hours ago
- The Print
Indian doctors more confident about oestrogen therapy for menopause as USFDA may scrap black box warning
The move came after the findings of a Women's Health Initiative (WHI) study—the largest-ever randomised controlled trial of hormone therapy in 2002—went public. The study found a combined oestrogen-progestin therapy linked to a rise in heart attacks and strokes, and a slightly elevated risk of breast and endometrial cancers. The USFDA, in 2003, mandated a black box warning—the highest level of warning associated with approved drugs when proven to be associated with serious or life-threatening adverse events—on all menopause treatments containing oestrogen, regardless of form or absorption rates. New Delhi: The United States Food and Drug Administration (USFDA) has declared its plan to remove the currently mandated, strictest health warning on oestrogen replacement therapies. The development has triggered a debate around the treatment, once widely used to manage menopausal symptoms but later linked to harmful side effects, such as cancer. However, the FDA panel, which held a discussion telecast publicly last month, was of the view that at least local oestrogen therapy, such as vaginal cream, is safe and should not carry the same warnings as systemically delivered oestrogen via patches or pills taken orally. The panel suggested that the risks associated with hormone replacement therapy (HRT) likely were overstated. The FDA has now invited submission of broad, public comments on the risks and benefits related to menopause hormone therapy, including 'data that could support updates to the labelling of such products'. Typically occurring between the ages of 45 and 55, menopause is the cessation of menstruation and the decline in ovarian function. This biological process comes with hormonal fluctuations, mainly the lowering of oestrogen and progesterone levels, which can lead to a variety of physical and psychological symptoms. A hallmark symptom of menopause is hot flashes, characterised by sudden waves of heat, flushing, and sweating, often accompanied by palpitations and feelings of anxiety. Additionally, many women experience night sweats while the drop in oestrogen levels has links to a marked rise in mood swings and behavioural changes, vaginal dryness, adverse bone health, cardiovascular events, and the risk of breast cancer. HRT had been a common approach since the 1970s to manage menopausal symptoms by supplementing the body with oestrogen, progesterone, or both. However, since 2000, following the WHI findings, most doctors and patients worldwide have been cautious in recommending or using it, and its popularity has dramatically dropped. In India, where HRT is available in the form of pills, vaginal creams, and topical cream applied on the arms, but no implants or patches, like in the US, there is no country-specific box warning, which is mandatory for the products in India. India never updated the official regulatory stance to reflect the advanced risk-benefit understanding associated with the treatment. However, experts maintained that clinicians had been hesitant in prescribing it. Now, many, including those in India, believe the situation will change. 'I am glad at the development concerning the warning status related to HRT for menopause,' Dr Archana Dwiwedi, the chair of the mid-life committee in the Federation of Obstetric and Gynaecological Societies of India (FOGSI), told ThePrint. A large number of women undergoing menopause or post-menopause can benefit majorly from HRT but remain deprived of it, mainly on account of evidence that may now be outdated, she said, adding that current scientific understanding is that HRT's benefits for most women far outweigh the risks. Also Read: What is the 'women's health gap' and how to close it 'Evolving' evidence In 1991, the National Institutes of Health in the US launched the WHI, a $625 million, long-term, randomised controlled study to investigate ways to prevent the leading causes of death and disability in postmenopausal women. The WHI recruited 1,61,808 postmenopausal women aged 50 to 79 for its study, and over 68,000 participated in one of three clinical trial arms—hormone therapy, diet modification, or calcium and vitamin D supplementation. The hormone therapy trial, intended to last nine years, would evaluate the long-term health impacts of the two most common HRT regimens at the time—conjugated equine estrogen (CEE-oestrogen derived from the urine of pregnant mares) plus progestin, or synthetic progesterone for women with a uterus and CEE alone for others who underwent a hysterectomy and no longer had a uterus. Eleven years later, the NIH announced that it was stopping the oestrogen-plus-progestin arm of the trial early, citing increased rates of blood clots, stroke, heart attacks, and breast cancer in women taking the combined hormone therapy. These findings led to a dramatic shift in the usage pattern of HRT globally, with a large number of patients and doctors abandoning it overnight. However, experts now say the WHI findings have since come under intense scrutiny, and an understanding has evolved that the results, which profoundly impacted the use of HRT, could have been skewed. For instance, the trial participants were old—63-year-olds on average—who in any case have a high baseline risk for cardiovascular conditions. Also, a follow-up study, which came out in 2024, concluded that HRT is safe and beneficial for most healthy women with bothersome menopause symptoms if they start it in the years shortly after menopause begins. 'The latest versions of HRT are also far safer and can make life easier for a high percentage of women, who face bothersome health challenges in the menopause stage, which severely affects their quality of life,' Dwiwedi said. There, however, are some sceptics too. 'I suspect the pharmaceutical industry pushed the latest FDA development. While the FDA panel batting for warning labels in the HRT shared a lot of anecdotal evidence to suggest they are safe, why was there not any scientific presentations to back those claims?' asked a gynaecologist with AlIMS Delhi, who did not wish to be named. However, while there is no clarity on whether the FDA will remove the requirement of black box warnings on all HRT for menopause, several of the panel members made a strong case for at least local oestrogen therapies, with comparatively low level of oestrogen, for symptoms such as vaginal dryness and urinary issues, as opposed to systemic therapies in the form of pills and implants. Some Indian clinicians agree with this argument. Vaginal oestrogen cream, mainly prescribed based on requirement, is not for a systemic replacement of oestrogen, but for local reasons, such as dryness or burning sensation, or poor urinary control or poor comfort level in terms of intercourse, said gynaecologist Dr Hemanandini Jayaraman from Manipal Hospital in Bengaluru. She said that the absorption of vaginal creams into the body is negligible, so no enhanced risk or risk factors are associated with the creams, which women generally use for local reasons. 'As far as continuing the vaginal application is concerned, if a patient gets symptomatic relief, which is extremely good, it can be safely pursued for a longer duration of time,' the clinician added. However, she also maintained that HRT, even in the form of oral prescription, could be safe provided there is regular monitoring of the users. Also Read: Over 50% of Indian women are anaemic. We need health literacy, support groups: Shabana Azmi Attitudes towards HRT in India India has nearly 15 crore women estimated to be postmenopausal, and roughly 30-40 percent of them could be considered potential candidates for HRT. 'These are women who are symptomatic and have no contraindications, such as prior hormone-sensitive cancers or high clotting risk, typically considered suitable candidates for HRT,' the Federation of Obstetrics & Gynaecological Societies of India (FOGSI) member said. However, according to estimates, less than five percent of women receive HRT. Currently, India follows a global prescription for norms for hormone therapy, including the USFDA as well as European guidelines. And while there is no equivalent to the FDA's black box warning on systemic risks like breast cancer, stroke, or clots here, the Indian drug monographs and medical literature still describe side effects for estrogen therapy, such as deep vein thrombosis, hypertension, breast and endometrial cancer, and dementia. Moreover, the guidelines from Indian expert groups mirror international concerns about systemic oestrogen use in women with certain risk factors, usually after age 60 or more than 10 postmenopause years, pointed out Dr Sweta Kumar, a gynaecologist and obstetrician with Surya Mother and Child Super Speciality Hospital in Pune. While many gynaecologists in India are aware of HRT and do prescribe it to some patients, a significant number are hesitant or prefer alternative options. Younger or less experienced clinicians tend to be more cautious, and alternative therapies are still quite common in practice, Kumar said. According to the 2025 national cross-sectional survey of 514 young Indian obstetricians-gynaecologists, the combined oestrogen-progestin therapy for vasomotor symptoms was recommended by 83 percent of the practitioners with three years' or below-three years' experience. When their experience range was seven to 10 years, fewer practitioners, 77 percent, recommended it. Moreover, younger doctors (0–3 years) were found less likely to support early initiation of therapy—30 percent of them—compared to more experienced ones—49 percent of them. A large number of patients also find HRT risky and are hesitant to use it, Dr N.S. Saradha, a senior gynaecologist with SIMS Hospital in Chennai, underlined. 'Women experiencing early or surgical menopause, accelerated bone loss, and high risk of osteoporosis benefit the most from HRT. I hope with the evolving understanding around HRT, both doctors and patients can make informed decisions on its usage,' Saradha said. (Edited by Madhurita Goswami) Also Read: AI can aid in early, precise detection of breast cancer, show results of 1st randomised trial
Time of India
6 hours ago
- Time of India
Now you don't need reading glasses, new FDA-approved eye drops can sharpen near vision
The US Food and Drug Administration has approved Vizz eye drops. These drops improve near vision for adults over 40. Lenz Therapeutics developed this aceclidine-based treatment. Vizz narrows the pupil, increasing focus. Clinical trials showed results within 30 minutes, lasting up to 10 hours. Common side effects include dim vision and eye irritation. Now you don't need reading glasses as FDA approves Vizz eye drops to sharpen near vision for up to 10 hours Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads The US Food and Drug Administration has approved Vizz, a once-daily prescription eye drop that can temporarily improve age-related blurry near vision, or presbyopia, for up to 10 by California-based Lenz Therapeutics , Vizz is the first FDA-approved aceclidine-based treatment for presbyopia in the United States. It is expected to be available in clinics and pharmacies starting in is a common condition affecting most adults over 40, making it harder to focus on close objects. People often rely on reading glasses or contact lenses to see clearly at close works by using aceclidine to narrow the pupil, creating a 'pinhole effect' similar to a camera lens adjustment. This increases depth of focus without blurring distance vision or causing the 'zoomed-in' effect seen with some previous late-stage clinical trials, results appeared within 30 minutes, peaked at three hours and lasted for as long as 10 hours. According to the company, 71 percent of participants could read at least three more lines on a near-vision chart without loss of distance clarity.'This FDA approval represents a disruptive paradigm shift in treatment options for millions of people who are frustrated and struggling with the inevitable age-related loss of their near vision,' said Vizz clinical investigator Marc Bloomenstein, from Schwartz Laser Eye Care Center in Scottsdale, Ariz., in a statement.'I believe this will be a welcome solution for both optometrists and ophthalmologists who will now be able to offer a highly effective and sought-after presbyopia treatment that could immediately become the standard of care, with a product profile that will meet our patients' side effects reported in trials included temporary dim vision, mild eye irritation and headaches. The FDA advises patients to avoid driving or operating heavy machinery until vision clears after using the drops and to be cautious in low-light Therapeutics says the drops will be available by prescription only.
Time of India
19 hours ago
- Time of India
The hidden danger of kratom: Two grieving mothers expose the deadly truth behind the 'natural' supplement
In recent years, kratom has emerged as a popular so-called 'natural' remedy, praised by its users for easing anxiety, pain, and even aiding in recovery from opioid addiction. Available in gas stations, wellness shops, and online stores across the United States, it is sold in the form of powders, capsules, gummies, and drinks. Its appeal lies in its plant-based origin and accessibility. But behind the glossy marketing and herbal branding lies a darker truth, one that two grieving mothers are now fighting to expose. Pam Mauldin's son, 37-year-old Jordan McKibban, died in April 2022 after consuming kratom in a seemingly harmless way by mixing a spoonful of the powder into a glass of lemonade after work. A resident of Washington state, Jordan was a health-conscious man who worked at an organic food distributor and avoided even ibuprofen for his arthritis. He loved cooking, being outdoors, and was planning a future with a woman he had fallen in love with. He dreamed of starting a family. But that dream ended abruptly in his bathroom. His mother found him lifeless, the result of mitragynine toxicity an active compound in kratom that behaves like an opioid. She performed CPR on her son, but it was too late. 'He shouldn't be in the cemetery,' Mauldin told The New York Post in an exclusive report published August 6, 2025. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Unsold 2021 Cars Now Almost Free - Prices May Surprise You Unsold Cars | Search Ads Learn More Undo 'I've lost my son. I've lost the grandchildren I could have had. I've lost the joy of watching him grow into the man he was becoming. ' Mauldin is now part of a growing number of Americans pushing for stricter regulation or an outright ban on kratom. Her wrongful death lawsuit claims that kratom is 63 times more deadly than other natural supplements legally sold to consumers. She finds it deeply frustrating that products like lettuce or potato chips are pulled from shelves over minor safety concerns, yet kratom remains widely available despite documented fatalities. Kratom is made from the leaves of a tree native to Southeast Asia. In lower doses, it stimulates the body. In higher doses, it acts as a sedative—just like opioids. According to the FDA, kratom is not legally marketed in the U.S. as a dietary supplement or food additive, yet it continues to thrive in the gray zones of commerce. One major concern is that kratom products are not required to go through quality control checks, meaning consumers have no assurance about what they are actually ingesting. Doctors like Dr. Robert Levy, an addiction specialist and professor at the University of Minnesota, warn that kratom's addictive potential is dangerously underestimated. 'People can become addicted to it, have withdrawal from it, and overdose on it,' Levy told The Post. 'There's a belief that because something is 'natural,' it must be safe. But arsenic is natural too.' The problem is amplified by a newer, more potent version of kratom circulating in the market: 7-hydroxymitragynine, commonly known as 7-OH. This synthetic kratom variant is more powerful than morphine and even more addictive. The FDA has recently recommended classifying 7-OH as an illicit substance. Dr. Marty Makary, the FDA Commissioner, stated, 'We need regulation and public education to prevent another wave of the opioid epidemic. ' Jennifer Young, a mother from Columbus, Ohio, also knows the pain kratom can inflict. Her 27-year-old son, Johnny Loring, began using kratom for anxiety. Like many others, Young didn't think much of it after reading online that it was a 'natural, safe alternative.' Loring was a delivery driver who loved fishing and playing guitar. 'Everybody loved Johnny,' she said. 'He was the kind of guy who would give you the last dollar in his pocket. ' Then he started having seizures. Doctors didn't connect them to kratom and referred him to a seizure clinic. He never made it. During a family mushroom-hunting trip, he collapsed and died. The toxicology report revealed high levels of mitragynine and gabapentin in his system. After his death, Young found nearly 20 packs of kratom hidden in his room. He would mix the powder into orange juice. She had no idea how addicted he had become. 'The level of kratom shocked me,' she said. 'It made my gut sick.' Young, too, has filed a wrongful death lawsuit. But her focus is not on the financial settlement. 'There's no amount of money I could put on my child's life,' she said. After losing Johnny, she spent a year in bed and began taking antidepressants. Her other children have struggled with mental health in the aftermath. Christmas was 'miserable,' she said. 'Our house is silent now. The void of Johnny is just loud.' Despite these tragic stories, kratom remains largely unregulated. From 2011 to 2017, poison control centers recorded over 1,800 calls related to kratom. Physicians say that number has only gone up. Dr. Michael Greco, an emergency medicine doctor, told The Post that patients on kratom often arrive at the hospital with agitation, psychosis, dizziness, elevated blood pressure, or are completely unresponsive. For now, grieving families are doing what the federal government has not: warning the public. They want parents, teenagers, and health-conscious consumers to understand that 'natural' does not mean harmless. Both Mauldin and Young believed their sons were making responsible choices. Both were wrong. As these cases show, kratom is not the safe, plant-based wonder product it is made out to be. It is an addictive substance with the potential to destroy lives. Regulation is long overdue. Until that happens, awareness is the only defense parents and families have. As Mauldin put it: 'He didn't even like to take ibuprofen. That's the kind of man he was. He trusted what was on the label. And now he's gone.' How does kratom affect the body? The wisdom Kratom, a lush tree native to Southeast Asia, has come a content of heated discussion in heartiness circles, indispensable drug forums, and nonsupervisory debates. In regions like Thailand and Indonesia, the factory's leaves have long been used by sloggers seeking relief from physical strain or internal fatigue. Over the once decade, its dried or pulverized form has gained traction in Western requests, frequently promoted as a natural remedy for pain, anxiety, and low energy. Yet, the line between benefit and detriment is thin. Kratom's impact on the mortal body isn't only complex, it's also changeable, especially in the absence of regulation. How the body responds? Kratom generally begins working within half an hour of ingestion. The peak of its goods generally hits within two hours and may last up to five or six. During this time, the body may suffer a conspicuous shift in energy or mood. Common short- term goods include Increased energy and talkativeness( low boluses) Muscle relaxation and pain relief( high boluses) A calmer or further balanced mood Mild swoon or internal clarity jacked focus or bettered work performance Not all gests are positive. Indeed moderate use has touched off side goods in some individualities Nausea or puking Dizziness or blurred vision Sot mouth or sweating Trouble concentrating Fatigue after the goods wear off These symptoms may vary depending on body weight, general health, former exposure to instigations, and whether kratom is taken alone or with other substances. The current medical station Kratom's legal status varies across regions. In the U.S., it remains legal under civil law but is confined or banned in certain countries. The FDA has expressed concern about its eventuality for abuse, while others argue that banning kratom outright could push druggies toward more dangerous synthetic opioids. Medical professionals generally advise caution. Until large- scale studies clarify kratom's long- term impact, especially on the liver, brain, and heart, it's wise to treat the factory as a serious pharmacological agent not just a herbal tea. Kratom is neither a panacea nor a substance to be taken smoothly. Its goods on the mortal body can be remedial in some cases and dangerous in others. As the heartiness assiduity continues to experiment with natural druthers, kratom sits at a critical crossroads, promising for some, problematic for numerous. Anyone considering its use should speak to a certified healthcare provider and insure they're sourcing it from a estimable supplier, if at all. Source of the case: The New York Post, "Our sons died taking an 'all-natural' supplement you can buy at gas stations people don't realize it's so addictive and dangerous", August 6, 2025. ( source of image Pinterest) Get the latest lifestyle updates on Times of India, along with Raksha Bandhan wishes , messages and quotes !
